Netherlands Outlines 2040 Biotech Vision, Emphasizing Tools, Commercialization, and Regulatory Reform
The Dutch government has released a national strategy to position the Netherlands as a global leader in biotechnology by 2040. …
All Posts
Sanger and PacBio Launch Long-Read Effort to Decode Immune Gene Activity
A new collaboration between the Wellcome Sanger Institute and Pacific Biosciences (PacBio) will apply long-read, single-cell RNA sequencing to nearly …
Finalists Announced for $10M Coller Dolittle Challenge on AI-Powered Interspecies Communication
The Coller Dolittle Challenge has announced its shortlist of four research teams competing for its inaugural $100,000 annual prize, part …
BayPine Acquires Clinical Trial Network CenExel, Plans Digital Infrastructure and AI Expansion
CenExel Clinical Research, a U.S. site network specializing in complex therapeutic areas such as central nervous system (CNS) disorders, will …
Biostate AI to Develop Predictive Models for Multiple Sclerosis Using Transcriptomic Data
Biostate AI, a startup building AI models from RNA sequencing data, has partnered with the Accelerated Cure Project (ACP) to …
Scotland Launches ‘AI Discovery’ to Foster DeepTech AI Startups for NHS Healthcare Innovation
A new programme titled AI Discovery has been launched in Scotland to bridge advanced academic research with real-world healthcare applications …
Chiba University Researchers Develop Low-Cost Cell-Based Assay to Detect Chemical-Induced Epigenetic Changes
Researchers at Chiba University, in collaboration with Japan’s National Institute of Health Sciences, have developed a novel cell-based assay that …
FDA Plan to Replace Animal Testing with AI Models and Human-Based Methods in Drug Evaluation Shift
The U.S. Food and Drug Administration announced a major policy change on April 10, 2025, signaling its intent to reduce …
Ingenix.ai Secures €9M to Advance Multimodal AI Foundation Model for Simulating Clinical Trials
Warsaw-based biotech company Ingenix.ai has closed a €9 million funding round to support the development of its proprietary foundation model …
Recursion and Enamine Release AI-Curated Screening Libraries Targeting 100 Challenging Drug Targets
Recursion and Enamine announced the release of ten curated screening libraries generated through their AI-enabled collaboration. The libraries are designed …
First Genetically Engineered Dire Wolf-Like Animals Born
De-extinction company Colossal Biosciences has produced three genetically engineered animals with dire wolf-like traits using a gene-editing approach applied to …
Recursion Doses First Patient in Phase 1 Trial of AI-Designed MALT1 Inhibitor
Recursion has dosed the first patient in its Phase 1 EXCELERIZE trial of REC-3565, a selective MALT1 inhibitor targeting relapsed …